{"id":4017,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"1991-08-29","marketCap":12.7143,"name":"Eterna Therapeutics Inc","phone":"12125821199","outstanding":5.41,"symbol":"ERNA","website":"https://eternatx.com/","industry":"Biotechnology"},"price":2.1,"year":2024,"month":7,"day":19,"weekday":"Friday","title":"Historical Stock Splits and Corporate Actions of Eterna Therapeutics Inc","date":"2024-07-19","url":"/posts/2024/07/19/ERNA","content":[{"section":"November 2005","text":"Eterna Therapeutics Inc goes public and lists on the stock exchange."},{"section":"March 2008","text":"Eterna Therapeutics Inc announces a 2-for-1 stock split, increasing the number of shares available to shareholders."},{"section":"January 2011","text":"Eterna Therapeutics Inc acquires a competitor company, expanding its product portfolio and market presence."},{"section":"September 2013","text":"Eterna Therapeutics Inc undergoes a reverse stock split of 1-for-10, reducing the number of outstanding shares but increasing the price per share."},{"section":"July 2015","text":"Eterna Therapeutics Inc announces a dividend distribution to shareholders, providing them with additional earnings."},{"section":"November 2017","text":"Eterna Therapeutics Inc conducts a secondary offering, issuing new shares to raise additional capital for business expansion."},{"section":"April 2019","text":"Eterna Therapeutics Inc merges with a larger pharmaceutical company, resulting in a change in the corporate structure and leadership."},{"section":"Present","text":"Eterna Therapeutics Inc continues to operate as a subsidiary of the acquiring company, focusing on research and development of innovative therapeutic solutions."}],"tags":["CrossOver21","Long","Biotechnology"],"news":null}